IGF DES 1-3 Pharmaqo 1mg (INT)
$50.00
Brand: Pharmaqo Labs
Raw material: IGF-1 DES
Package: 1mg/vial
Stock: International
Technical Analysis of Localized Cellular Growth
In the field of molecular biology, IGF DES is a shortened version of the native Insulin-like Growth Factor-1 molecule. By removing the first three amino acids from the N-terminus, the peptide loses its ability to be inhibited by binding proteins, making it significantly more potent for immediate tissue interaction. At globalanabolicsteroids.com, we provide this data to support research into localized muscle repair and the creation of new muscle fibers within targeted muscle groups.
Molecular Architecture and 2025 Potency Standards
The unique pharmacokinetic profile of IGF DES is achieved through a specific truncation that differentiates it from the endogenous 70-amino acid hormone:
-
Des(1-3) Truncation: By removing the Glu-Pro-Arg sequence, the peptide becomes immune to Insulin-like Growth Factor Binding Proteins (IGFBPs). This allows almost 100 percent of the peptide to be biologically active upon administration.
-
Shortened Amino Acid Count: The resulting 67-amino acid chain is highly unstable in the general circulation but possesses a 10 times higher affinity for the IGF-1 receptor compared to the standard hormone.
-
Lactic Acid Synergy: During intense research protocols, the presence of lactic acid in muscle tissue actually changes the shape of the IGF receptor, making the binding of the peptide even more effective during exercise.
Technical Specifications
For laboratory documentation and analytical modeling, the following data defines the compound:
| Property | Scientific Detail |
| Active Substance | Des(1-3) Insulin-like Growth Factor-1 |
| Amino Acid Count | 67 |
| Active Half-Life | 20 to 30 Minutes |
| Purity Standard | 98 percent or higher (HPLC Verified) |
Core Research Mechanisms in 2025
This peptide is utilized in advanced protocols to observe the limits of localized growth:
-
Site-Specific Hyperplasia: Unlike systemic analogs, IGF DES is studied for its ability to induce hyperplasia—the creation of new muscle cells—specifically in the muscle group where it is administered.
-
Satellite Cell Proliferation: Researchers use this analog to trigger the rapid division of satellite cells, which is critical for repairing micro-trauma and increasing muscle density within a short window of time.
-
Enhanced Pump Dynamics: By increasing glucose uptake and blood flow at the injection site, IGF DES is frequently researched for its ability to create extreme muscle fullness and vascularity during training.
Laboratory Handling and Safety
-
Reconstitution: The lyophilized powder should be reconstituted with 0.6 percent acetic acid. For 2025 research standards, keeping the solution at a slightly acidic pH is vital to prevent the 67-amino acid chain from degrading.
-
Timing of Administration: Because of its 20 to 30 minute half-life, researchers typically apply the compound 15 minutes before or immediately after stimulating a specific muscle group.
-
Storage: Once mixed, the solution must be kept in a cold environment between 2 and 8 degrees Celsius.
Quality Commitment at GlobalAnabolicSteroids.com
Reliable research requires high-purity peptides free from truncated fragments or bacterial contaminants. At globalanabolicsteroids.com, our IGF DES is verified via mass spectrometry to ensure the exact 67-amino acid sequence. We provide the pharmaceutical standards necessary for 2025 studies into the cutting edge of localized muscle regeneration.
Benefits
-
- Increased Muscle Mass: Supports significant gains in muscle size and strength.
Additionally, PT-141 has been shown to support various physiological enhancements during studies.
- Improved Performance: Enhances endurance and reduces recovery times during workouts.
- Stable Hormone Levels: Helps maintain consistent testosterone levels in the body.
Dosage and Administration
-
- Typical Dosage: Commonly administered in doses ranging from 375 mg to 750 mg per week, tailored to individual goals and experience levels.
- Administration: Injected intramuscularly, usually once a week.
Researchers often note the effectiveness of PT-141 in various testing conditions.
Potential Side Effects
- Estrogenic Effects: Risk of water retention, gynecomastia, and mood swings.
- Androgenic Effects: Possible side effects include acne, hair loss, and increased aggression.SStanozolol
- Cardiovascular Risks: Long-term use can lead to elevated blood pressure and cholesterol levels.
Considerations
-
- Consultation Required: It’s important to consult a healthcare professional before use, especially for those with existing health conditions.
Understanding the use of PT-141 is vital for well-informed research practices.
- Legal Compliance: Ensure adherence to local laws regarding the purchase and use of anabolic steroids.
| Brand |
Pharmaqo Labs International |
|---|---|
| SHIPPING LOCATIONS |
INTERNATIONAL SHIPPING |

Reviews
There are no reviews yet.